Cargando…
COVID-19 infection in first trimester of pregnancy marked by a liver cytolysis in a woman previously treated by hydroxychloroquine for repeated implantation failure: a case report
BACKGROUND: In December 2019, a new disease (COVID-19) caused by a novel coronavirus called SARS-CoV-2 emerged in China and spread to many other countries. There is only limited data about the clinical features of COVID-19 during pregnancy, especially in first trimester. CASE PRESENTATION: We report...
Autores principales: | Lamazou, F., Oger, P., Dieli-crimi, R., Guerin, A., Letouzey, V., Octernaud, S., Place, V., Calès, P., Descamps, P., Delaroche, L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667476/ https://www.ncbi.nlm.nih.gov/pubmed/33198681 http://dx.doi.org/10.1186/s12879-020-05551-0 |
Ejemplares similares
-
Evaluation of SARS-CoV-2 in semen, seminal plasma, and spermatozoa pellet of COVID-19 patients in the acute stage of infection
por: Delaroche, Lucie, et al.
Publicado: (2021) -
Energy metabolism and T-cell-mediated cytolysis. II. Selective inhibition of cytolysis by 2-deoxy-D-glucose
Publicado: (1977) -
Cytolysis of fibroblasts by C3a.
por: Temple, A., et al.
Publicado: (1980) -
Integration of a virus membrane protein intothe lipid bilayer of target cells as a prerequisite for immune cytolysis. Specific cytolysis after virosome- target cell fusion
por: Morein, B, et al.
Publicado: (1979) -
Modulation of Reoviral Cytolysis (II): Cellular Stemness
por: Bourhill, Tarryn, et al.
Publicado: (2023)